Literature DB >> 25696585

Heart transplantation in the Netherlands: quo vadis?

J H Kirkels, N de Jonge, C Klöpping, J R Lahpor, L A van Herwerden, A H M M Balk, A J J C Bogers, A P W M Maat, P A F M Doevendans.   

Abstract

Heart transplantation is limited by the lack of donor organs. Twenty years after the start of the Dutch transplant programmes in Rotterdam and Utrecht the situation has even worsened, despite efforts to increase the donor pool. The Dutch situation seems to be worse than in other surrounding countries, and several factors that may influence donor organ availability and organ utilisation are discussed. The indications and contraindications for heart transplantation are presented, which are rather restrictive in order to select optimal recipients for the scarce donor hearts. Detailed data on donor hearts, rejected for transplantation, are shown to give some insight into the difficult process of dealing with marginal donor organs. It is concluded that with the current low numbers of acceptable quality donor hearts, there is no lack of capacity in the two transplanting centres nor is the waiting list limiting the number of transplants. The influence of our current legal system on organ donation, which requires (prior) permission from donor and relatives, is probably limited. The most important determinants of donor organ availability are: 1. The potential donor pool, consisting of brain dead victims of (traffic) accidents and CVAs and 2. Lack of consent to a request for donation. The potential donor pool is remarkably small in the Netherlands, due to relatively low numbers of (traffic) accidents, with an almost equal number of CVA-related brain dead patients compared with neighbouring countries. Lack of consent can only be pushed back by improved public awareness of the importance of donation and improved skills of professionals in asking permission in case there is no previous consent.

Entities:  

Keywords:  Netherlands; heart transplantation

Year:  2006        PMID: 25696585      PMCID: PMC2557340     

Source DB:  PubMed          Journal:  Neth Heart J        ISSN: 1568-5888            Impact factor:   2.380


  5 in total

1.  Opting-out systems: no guarantee for higher donation rates.

Authors:  Remco Coppen; Roland D Friele; Richard L Marquet; Sjef K M Gevers
Journal:  Transpl Int       Date:  2005-11       Impact factor: 3.782

2.  Routine screening of donor hearts by coronary angiography is feasible.

Authors:  O Grauhan; C Wesslau; R Hetzer
Journal:  Transplant Proc       Date:  2006-04       Impact factor: 1.066

3.  Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult heart transplantation report--2006.

Authors:  David O Taylor; Leah B Edwards; Mark M Boucek; Elbert P Trulock; David A Waltz; Berkeley M Keck; Marshall I Hertz
Journal:  J Heart Lung Transplant       Date:  2006-07-10       Impact factor: 10.247

4.  Waiting for a thoracic transplant in Eurotransplant.

Authors:  Jacqueline M A Smits; Johan Vanhaecke; Axel Haverich; Erwin de Vries; Leo Roels; Guido Persijn; Gunther Laufer
Journal:  Transpl Int       Date:  2006-01       Impact factor: 3.782

5.  Estimating the number of potential organ donors in the United States.

Authors:  Ellen Sheehy; Suzanne L Conrad; Lori E Brigham; Richard Luskin; Phyllis Weber; Mark Eakin; Lawrence Schkade; Lawrence Hunsicker
Journal:  N Engl J Med       Date:  2003-08-14       Impact factor: 91.245

  5 in total
  2 in total

1.  Guidelines for heart transplantation.

Authors:  N de Jonge; J H Kirkels; C Klöpping; J R Lahpor; K Caliskan; A P W M Maat; J Brügemann; M E Erasmus; R J M Klautz; H F Verwey; A Oomen; C H Peels; A E J Golüke; D Nicastia; M A C Koole; A H M M Balk
Journal:  Neth Heart J       Date:  2008       Impact factor: 2.380

2.  Thirty years of heart transplantation at the University Medical Centre Utrecht.

Authors:  A Sammani; A M Wind; J H Kirkels; C Klöpping; M P Buijsrogge; F Z Ramjakhan; F W Asselbergs; N de Jonge
Journal:  Neth Heart J       Date:  2017-09       Impact factor: 2.380

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.